other material
confidence high
sentiment neutral
materiality 0.50
Eledon Pharmaceuticals enters $75M at-the-market equity facility with Guggenheim Securities
Eledon Pharmaceuticals, Inc.
- ATM sales agreement with Guggenheim Securities for up to $75M in common stock sales.
- Shares sold directly on Nasdaq under Rule 415; 3.0% gross proceeds commission to Guggenheim.
- Company may terminate agreement with ten trading days' notice; no obligation to sell.
- Shelf registration statement on Form S-3 filed concurrently; subject to SEC effectiveness.